bathursti@mmv.org Telephone +41 (22) 799 4084 Fax +41 (22) 799 4061 Insitution Medicines for Malaria Venture (MMV) Address ICC Building, Route de Pre-Bois 20 Home Page http://www.mmv.org
|
Dr Ian BathurstIan Bathurst is the Director of Drug Research and Technology at MMV. His career has been focused on the use of recombinant DNA technologies to detect, prevent and treat disease. Ian has a wealth of research and industry experience in New Zealand, United Kingdom, and the USA.
The Medicines for Malaria Venture (MMV) is a non-profit organisation dedicated to reducing the burden of malaria in disease-endemic countries by discovering, developing and delivering safe, effective, and affordable antimalarial drugs through effective public-private partnerships. After seven years of operation, MMV is managing the largest-ever portfolio of malaria drug research with over 30 projects in different stages of drug research and development of which three new artemisinin combination therapies (ACTs) have completed phase III clinical trials and are ready for registration by a stringent regulatory authority. MMV’s goal is to register at least one new antimalarial before 2010 and maintain a sustainable pipeline of antimalarials to meet the needs of the 3.2 billion people at risk from this deadly disease. For further information please consult http://www.mmv.org |
